Filter by
JRC news and updates (13)
RSSThe JRC brought together academia, industry, researchers and health professionals to discuss nuclear competences and skills required to sustain medical applications of nuclear science.
What are the most promising current and emerging technologies when the next airborne disease hits?
JRC science helps you make sense of technologies against diseases that spread through the air.
Analysis of patented biotechnology inventions worldwide shows how the EU positions itself compared to the US and China.
Among the 2023 highlights: new in vitro methods under consideration for regulatory application, a virtual reality application for education in schools, and enhancing collaboration to promote innovative non-animal approaches.
Discover what it is like to be a scientist where research and policy combine.
The number of people living with a cancer diagnosis is increasing in the EU, partly due to an ageing population.
Exacerbated by an ageing population, the burden of cancer is increasing, with the number of new cases reaching 2.74 million in 2022.
How the JRC contributed to developing the EU common list of COVID-19 antigen tests that has allowed millions to safely travel during the pandemic. A great example of how the JRC’s science benefits everyone in Europe!
Tracing COVID-19 in clinical swabs and wastewater: our methods and reference materials.